Source:http://linkedlifedata.com/resource/pubmed/id/16788093
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
7-8
|
| pubmed:dateCreated |
2006-8-2
|
| pubmed:abstractText |
To review literature evaluating the use of fondaparinux for thromboembolic treatment and prophylaxis in patients with heparin-induced thrombocytopenia (HIT).
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
1060-0280
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
40
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1383-7
|
| pubmed:meshHeading | |
| pubmed:articleTitle |
Fondaparinux for thromboembolic treatment and prophylaxis of heparin-induced thrombocytopenia.
|
| pubmed:affiliation |
Virginia Commonwealth University Medical Center/Medical College of Virginia Hospitals, Richmond, 23298, USA. lefird@mcvh-vcu.edu
|
| pubmed:publicationType |
Journal Article,
Review
|